Biological E.’s vaccine approved for advanced trials on children
The Hindu
Corbevax becomes the third India-made vaccine that may be available for use in children
Hyderabad-based pharmaceutical company Biological E. Limited has been approved by the Drugs Controller General of India (DCGI) to conduct further trials of its vaccine Corbevax on children and adolescents. Following Zycov-D by Zydus Cadilla and Covaxin by Bharat Biotech, Corbevax becomes the third India-made vaccine that may be available for use in children. Zycov-D has already received authorisation for emergency use in children who are over 12 years. Covaxin is being tested in children who are younger and officials have said that the vaccine is likely to be ready by September.More Related News

NPCIL is to blame for storage of radioactive waste on site of Kudankulam nuclear power plant: Appavu
Tamil Nadu Speaker Appavu criticizes NPCIL for unsafe nuclear waste storage at Kudankulam, urging better solutions for public safety.












